Clinical trial
The Performance of Patient Support Program in Early Stage Breast Cancer
NCT00769080
Study timeline
Study start (unknown)2008-09-01Date precision: month
Registry last updated2011-11-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
BeijingBeijing Municipality, China1ShanghaiShanghai Municipality, China1GuangzhouGuangdong, China1HangzhouZhejiang, China1NanjingJiangsu, China1ChangshaHunan, China1WuhanHubei, China1ChengduSichuan, China1TianjinTianjin Municipality, China1ChongqingChongqing Municipality, China1HarbinHeilongjiang, China1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00769080 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.